Structural Heart Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Structural Heart Market Expected To Expand Between 2025 And 2029?

The valuation of the structural heart segment has experienced robust expansion lately; projections indicate an upward trend moving from a figure of $14.9 billion in 2024 to reach $15.89 billion by 2025, reflecting a consistent annual growth rate of 6.6%. Factors fueling this expansion through the past period include heightened levels of both public consciousness and diagnostic procedures, greater durability within the supply chain, rising outlays on medical services, the consolidation of market players, and a growing understanding regarding ailments of the heart and blood vessels.

Anticipating robust expansion, the overall market for structural heart devices is projected to reach a valuation of 22.48 billion dollars come 2029, achieving a compounded annual growth rate of 9.1% throughout the projection timeframe. This upward trajectory is fundamentally driven by several factors, including the increasing requirement for heart valve replacements, the demographic shift towards an older populace, the escalating prevalence of heart-related ailments, the finer divisions within the market itself, and burgeoning expansion across various geographic sectors. Key developments anticipated to shape this period involve the introduction of new products, continuous progress in medical technology, a rebound in economic conditions, the enforcement of new regulations, a greater frequency of cardiovascular disease occurrences, and the emergence of novel medical instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Structural Heart Industry?

Anticipated escalation in structural heart market expansion is directly linked to the increasing incidence of ailments affecting the cardiovascular system, encompassing conditions like heart failure, stroke, and coronary artery disease, which impact the heart and its associated vessels. This surge in cardiovascular issues is primarily fueled by demographic shifts towards an older population, evolving dietary habits and life choices, alongside growing obesity and diabetes figures. Structural heart interventions provide a means for diagnosing and treating irregularities in the heart’s chambers, valves, or surrounding structures, generally through less invasive methods compared to traditional open-heart surgery, thereby offering a pathway to effective care with reduced complication risks. To illustrate this trend, data released in August 2022 by the American College of Cardiology, a US-based medical organization, projected that all four significant cardiovascular risk factors in the United States would see an uptick between 2025 and 2060; diabetes is forecasted to have the most significant leap at 39.3%, bringing the total to 55 million people, while dyslipidemia is expected to rise by 27.6% (to 126 million), hypertension by 25.1% (to 162 million), and obesity by 18.3% (to 126 million). Furthermore, researchers noted that projected increases in cardiovascular disease rates were highest for heart failure, anticipated to grow by 33.4% (reaching 13 million cases), and stroke, up by 33.8% (to 15 million), succeeded by ischemic heart disease with a 30.7% increase (to 29 million) and heart attacks increasing by 16.9% (to 16 million), underscoring how the growing burden of cardiovascular disorders stimulates the structural heart market.

What Are The Major Segment Categories Driving The Structural Heart Market Growth?

The structural heartmarket covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

How Are Emerging Market Trends Shaping The Structural Heart Industry Landscape?

A pivotal force sweeping through the structural heart arena is the relentless march of technological progress, which is rapidly increasing in prominence. Leading entities within the structural heart sector are intensely focused on the development of novel offerings as means to solidify their competitive standing. A concrete illustration of this is the introduction by Eko Health, a digital health firm based in the United States, in February 2023, of the SENSORA platform, engineered for the non-invasive detection of cardiac diseases within settings of primary care. This SENSORA system incorporates artificial intelligence capabilities designed to impartially pinpoint structural murmurs, which signal the presence of valvular heart disease, alongside software for analyzing the patient care journey. By capturing and analyzing both electrical signals and heart sounds via its digital stethoscopes, this tool furnishes insights and measurements regarding subsequent patient treatment steps across the healthcare continuum. The objective of this technology is to support critical choices by flagging deficiencies in current care protocols, which subsequently stand to improve operational effectiveness—manifesting as shorter wait times for treatment commencement, reduced hospital stays, and fewer readmissions—concurrently boosting contentment levels for both patients and medical practitioners.

Who Are The Core Companies Influencing The Structural Heart Market Landscape?

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Structural Heart Market?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Structural Heart Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2025, By The Business Research Company

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795